From Molecular Discovery to Clinical Deployment
We collaborate with pharmaceutical and biotechnology companies to execute end-to-end translational programs — from multi-omics discovery and biomarker validation to clinical assay build-out, regulatory integration, and IP protection.
Founder’s Perspective-
Translational success requires more than strong science — it requires alignment across discovery, validation, assay development, regulatory readiness, and intellectual property strategy.
That is why we built an integrated execution model. When we partner with a team, we commit to moving the science all the way forward — not stopping at a dataset, but delivering clinically deployable and defensible outcomes.
We view every collaboration as a shared build.
— Qing Wang
Let’s Build
What Moves to Clinic
Whether you are advancing a discovery program, validating biomarkers, or preparing for clinical deployment, our team is ready to partner with you.
- Confidential scientific discussion
- Translational feasibility assessment
- Structured partnership proposal
Innovations in laboratory services
Turning biology into high-resolution data.
At Complete Omics, we are building the next-generation molecular measurement infrastructure for medicine. Our proprietary platforms combine ultra-deep proteomics, metabolomics, and multi-omics analytics to reveal disease biology at unprecedented resolution—enabling earlier detection, smarter drug development, and truly data-driven healthcare.
What type of laboratory services do you perform?
Complete Omics provides next-generation multi-omics laboratory services powered by our proprietary Complete360® platform and Valid-NEO® platform. We specialize in ultra-deep molecular profiling—including proteomics, metabolomics, lipidomics, immunopeptidomics, and targeted assays—from minimal clinical samples.
Our platform transforms biological samples into high-resolution molecular datasets, enabling biomarker discovery, precision diagnostics development, and large-scale clinical research.
Can I customize the service?
Yes. Our platform is built for flexible, project-specific experimental design. Clients can combine multiple analytical layers—such as proteomics, metabolomics, lipidomics, immunopeptidomics, and genomic assays—within a single integrated workflow. This allows researchers and industry partners to move beyond single-marker testing toward systems-level biological insight, accelerating discovery and translational development.
Do you offer non-disclosure signature?
Absolutely. We routinely operate under strict confidentiality agreements with academic institutions, biotechnology companies, pharmaceutical partners, and healthcare organizations.
All projects can be protected by mutual non-disclosure agreements (NDAs), ensuring that proprietary data, novel discoveries, and intellectual property remain fully protected throughout the collaboration.
Do you issue refunds?
Because our services involve custom service design, specialized reagents, and dedicated instrument time, projects are generally non-refundable once laboratory processing begins.
However, we prioritize scientific success and client satisfaction. If technical issues arise, our team works closely with partners to repeat analyses, optimize workflows, or generate additional data to ensure the project meets scientific objectives.